To access this element change to forms mode OFF
Grant Award View - GA278330
Developing a new type of drug for inflammatory lung disease
GA ID:
GA278330
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
7-Dec-2022
Publish Date:
9-Jan-2023
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2025
Value (AUD):
$981,805.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Development Grants
Grant Activity:
Developing a new type of drug for inflammatory lung disease
Purpose:
Millions of Australians have breathing difficulties due to viral/bacterial infections or environmental allergens/pollutants (dust mites, pollen, food, smoke) that trigger inflammation leading to lung disease (e.g. asthma, COPD, fibrosis). We have discovered a new type of drug that blocks inflammation in human cells and damage in mouse models of lung disease. This study can improve drug potency, selectivity and effectiveness and provide proof of concept preclinical data to enable clinical trials.
GO ID:
GO Title:
NHMRC Development Grants 2022 for funding in 2023
Internal Reference ID:
2022/GNT2022121
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, QLD
Postcode:
Multiple
Country:
AUSTRALIA